NA

Natural Alternatives International IncNASDAQ NAII Stock Report

Last reporting period 31 Mar, 2024

Updated 17 Sep, 2024

Last price

Market cap $B

0.041

Micro

Exchange

XNAS - Nasdaq

NAII Stock Analysis

NA

Uncovered

Natural Alternatives International Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

23/100

Low score

Market cap $B

0.041

Dividend yield

Shares outstanding

6.04 B

Natural Alternatives International, Inc. is a formulator, manufacturer, and marketer of nutritional supplements. The Company’s segments include private-label contract manufacturing, and patent and trademark licensing. Private-label contract manufacturing segment is engaged in the provision of private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, nutritional supplements, and other health care products. Patent and trademark licensing segment owns a patent estate related to the raw material ingredient known as beta-alanine, which is primarily commercialized through the direct sale of this raw material and supply agreements with third parties for the distribution and use of this raw material under its CarnoSyn and SR CarnoSyn trademarks. Its private-label contract manufacturing products are sold in the United States, Europe, Australia, Asia, Mexico, and Canada.

View Section: Eyestock Rating